The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 11, 2018

Primary Completion Date

May 29, 2018

Study Completion Date

May 29, 2018

Conditions

Chronic Hepatitis c

Interventions

DRUG

Kangdaprevir Sodium Tablet

Tablet，administered orally once daily

DRUG

placebo

Tablet，administered orally once daily

Trial Locations (1)

the First Hospital of Jilin University, Changchun

All Listed Sponsors

lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT03811678 - The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter